Lupine Share: Got green signal from America
Drug manufacturing giant Lupine has received approval from the US Department of Health (USFDA) to sell the new medicine. The company will now launch diabetes medicine (Dapagliflozin) in America, which is expected to increase the company’s earnings.
Torrent Pharma Share: Factory investigated
The US authorities (USFDA) have completed the investigation of Torrent Pharma’s Gujarat-based cancer drug manufacturing factory. Investors will keep an eye on how the investigation report comes out today.